Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease - PubMed (original) (raw)
Comparative Study
. 2004 Oct;4(10-11):1307-18.
doi: 10.1016/j.intimp.2004.05.006.
Affiliations
- PMID: 15313429
- DOI: 10.1016/j.intimp.2004.05.006
Comparative Study
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
Iwona Kurkowska-Jastrzebska et al. Int Immunopharmacol. 2004 Oct.
Abstract
The pathological process of neurodegeneration, which is observed in Alzheimer's (AD) and Parkinson's (PD) diseases and that follows any insult to the central nervous system, is accompanied by an inflammatory reaction, which is believed to contribute to the pathogenesis of the diseases. In accordance to this, the anti-inflammatory agents are suggested to be effective in slowing or inhibiting the degenerative process. In this study, we investigated the influence of dexamethasone (DXM) on the nigrostriatal dopaminergic neurons damage following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine (MPTP). Mice C57BL received pre-treatment of the various doses of dexamethasone followed by MPTP administration (40 mg/kg). We found that dexamethasone 1 mg/kg diminished a dopamine content depletion in striatum by about 20%, when the doses of 0.1 mg/kg was ineffective and 10 mg/kg even aggravate the dopamine content decrease. In the second step of the experiment, we chose the effective doses, 1 mg/kg, and started the treatment before and 24 h after MPTP administration. We observed the same protection in both situations: less dopamine depletion and less decrease in the number of dopaminergic cells in the substantia nigra (SN). Dexamethasone also similarly decreased the inflammatory reaction (glial activation, lymphocytic infiltration) in the injured areas. Our study showed that dexamethasone may exert a neuroprotective effect towards neurons injured by MPTP, but only when used in a proper dose. The mechanism of dexamethasone protective properties may be an inhibition of inflammatory process; however, direct interactions with neurons are also possible.
Similar articles
- Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW, Bradbury KA, Schneider JS. Anderson DW, et al. Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x. Eur J Neurosci. 2006. PMID: 17156378 - Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y. Kim NK, et al. Eur J Neurosci. 2009 Mar;29(5):891-900. doi: 10.1111/j.1460-9568.2009.06653.x. Epub 2009 Feb 24. Eur J Neurosci. 2009. PMID: 19245369 - Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T. Kurosaki R, et al. Eur Neuropsychopharmacol. 2005 Jan;15(1):57-67. doi: 10.1016/j.euroneuro.2004.05.007. Eur Neuropsychopharmacol. 2005. PMID: 15572274 - Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
Watanabe Y, Himeda T, Araki T. Watanabe Y, et al. Med Sci Monit. 2005 Jan;11(1):RA17-23. Med Sci Monit. 2005. PMID: 15614202 Review. - Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B. Morale MC, et al. Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5. Neuroscience. 2006. PMID: 16337092 Review.
Cited by
- Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications.
Giri PM, Banerjee A, Ghosal A, Layek B. Giri PM, et al. Int J Mol Sci. 2024 Apr 3;25(7):3995. doi: 10.3390/ijms25073995. Int J Mol Sci. 2024. PMID: 38612804 Free PMC article. Review. - Role of neuroinflammation in neurodegeneration development.
Zhang W, Xiao D, Mao Q, Xia H. Zhang W, et al. Signal Transduct Target Ther. 2023 Jul 12;8(1):267. doi: 10.1038/s41392-023-01486-5. Signal Transduct Target Ther. 2023. PMID: 37433768 Free PMC article. Review. - Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities.
Araújo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG. Araújo B, et al. Cells. 2022 Sep 17;11(18):2908. doi: 10.3390/cells11182908. Cells. 2022. PMID: 36139483 Free PMC article. Review. - Stress and brain immunity: Microglial homeostasis through hypothalamus-pituitary-adrenal gland axis and sympathetic nervous system.
Sugama S, Kakinuma Y. Sugama S, et al. Brain Behav Immun Health. 2020 Jul 23;7:100111. doi: 10.1016/j.bbih.2020.100111. eCollection 2020 Aug. Brain Behav Immun Health. 2020. PMID: 34589871 Free PMC article. Review. - TRP Channels Role in Pain Associated With Neurodegenerative Diseases.
Duitama M, Vargas-López V, Casas Z, Albarracin SL, Sutachan JJ, Torres YP. Duitama M, et al. Front Neurosci. 2020 Aug 4;14:782. doi: 10.3389/fnins.2020.00782. eCollection 2020. Front Neurosci. 2020. PMID: 32848557 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources